Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Meta Biomed Co., Ltd (059210)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
4,165.
00
+45
+1.0922%
₩
96.66B
Market Cap
-
P/E Ratio
420%
Div Yield
63,388
Volume
-
Eps
₩
4,120
Previous Close
Watching
Watch
Add Transaction
Day Range
4,040
4,180
Year Range
3,265
6,600
Want to track
059210
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Meta Biomed Co., Ltd (059210) Statistics
Valuation metrics
Market Cap
96.66B
Enterprise value
121.42B
Trailing P/E (ttm)
8.23
Forward P/E
4.31
PEG ratio
-0.25
Price/Sales (ttm)
0.94
Price/Book (mrq)
0.76
Enterprise Value/Revenue
1.18
Enterprise Value/EBITDA
4.3
Overview
Shares outstanding
27.17M
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
233.81K
Average volume (90 days)
226.49K
Price summary
52-Week low
3,265
52-Week high
6,600
Beta
-
50-Day moving average
4,272.1
200-Day moving average
5,038.93
Dividends and splits
Forward annual dividend rate
420
Forward annual dividend yield
0.1165%
Trailing annual dividend rate
105
Trailing annual dividend yield
0.0291%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
5 Jan 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
2:1
Last split Date
23 Apr 2010
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.52%
Operating margin
0.15%
Operational effectiveness
Return on assets
0.06%
Return on equity
0.09%
Income Statement
Revenue (ttm)
102.95B
Revenue per share (ttm)
4,103.68
Quarterly revenue growth (yoy)
-0.07%
Gross profit (ttm)
53.59B
EBITDA
28.5B
Net income to common (ttm)
10.99B
Diluted EPS (ttm)
438
Quarterly earnings growth (yoy)
-0.12%
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
-
Total debt (mrq)
44.24B
Total Debt/Equity (mrq)
0.35
Current ratio (mrq)
1.55%
Book value per share (mrq)
4,724.82
Cash Flow
Cash flow statement
7.61B
Levered free cash flow (LFCF)
10.99B